Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
Status:
Terminated
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
- To determine the effectiveness of goserelin acetate (Zoladex) in preserving ovarian
function in premenopausal women undergoing neoadjuvant and/or adjuvant chemotherapy for
primary invasive breast cancer by documenting persistence or resumption of regular
menses.
Secondary Objectives:
- To determine the incidence of pregnancy and the effect for participants' quality of life
(QOL) after chemotherapy.
- To determine the overall survival and disease-free survival times of study participants.